Results 1 to 10 of about 31,004 (198)

Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study

Acta Dermato-Venereologica, 2023
Photosensitizing properties of hydrochlorothiazide may increase skin cancer risk. To date, study findings on the association between hydrochlorothiazide use and skin cancer risk are inconsistent, notably regarding confounding and dose-response.
Marjolijn S. Haisma, Nathalie Greven, Mathanhy Logendran, Jens Bos, Bert v.d. Vegt, Barbara Horváth, Stijn de Vos, Geertruida H. de Bock, Eelko Hak, Emőke Rácz   +9 more
doaj   +2 more sources

Hydrochlorothiazide and chlorthalidone use and glaucoma risk: pharmacovigilance analysis and nationwide cohort study [PDF]

Frontiers in Pharmacology
Hydrochlorothiazide and chlorthalidone are widely used thiazide diuretics, and pharmacovigilance reports have suggested a possible link between their use and glaucoma.
Jooyoung Yoon, Jiyeong Kim, Ko Eun Kim, Jee-Eun Chung, Seong Joon Ahn   +4 more
doaj   +2 more sources

Synthesis of Lanthanium-doped ZnO Nanoflowers: Supported on Graphite Screen Printed Electrode for Selective and Sensitive Detection of Hydrochlorothiazide

International Journal of Electrochemical Science, 2019
In this paper, we report a novel electrochemical sensor for the sensitive detection of hydrochlorothiazide based on La3+/ZnO nanoflower supported on graphite screen printed Electrode.
Rasoul Rezaei, Mohammad Mehdi Foroughi, Hadi Beitollahi, Somayeh Tajik, Shohreh Jahani   +4 more
doaj   +2 more sources

Hydrochlorothiazide use is strongly associated with risk of lip cancer

Journal of Internal Medicine, 2017
The diuretic hydrochlorothiazide is amongst the most frequently prescribed drugs in the United States and Western Europe, but there is suggestive evidence that hydrochlorothiazide use increases the risk of lip cancer.
Anton Pottegard, Jesper Hallas, Mathias Tiedemann Svendsen   +2 more
exaly   +2 more sources

Per‐Protocol Analysis of Chlorthalidone Versus Hydrochlorothiazide for Cardiovascular Event Prevention—Diuretic Comparison Project [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The DCP (Diuretic Comparison Project), a pragmatic trial, evaluated whether chlorthalidone compared with hydrochlorothiazide would reduce the risk of nonfatal cardiovascular disease or noncancer‐related death.
Sonia T. Anand, Cynthia Hau, Michael J. Davenport, Areef Ishani, William C. Cushman, Peter A. Glassman, Addison A. Taylor, Robert A. Lew, Ryan E. Ferguson, Sarah M. Leatherman   +9 more
doaj   +2 more sources

Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study

Journal of the American Academy of Dermatology, 2019
BACKGROUND Hydrochlorothiazide use has been associated with markedly increased risk for squamous cell carcinoma. No previous studies have investigated the association between hydrochlorothiazide use and the risk for Merkel cell carcinoma (MCC) and ...
Sidsel Arnspang Pedersen, Lisbet Rosenkrantz Hölmich, Anton Pottegard   +2 more
exaly   +2 more sources

Method Validation for Simultaneous Quantification of Olmesartan and Hydrochlorothiazide in Human Plasma Using LC-MS/MS and Its Application Through Bioequivalence Study in Healthy Volunteers

Frontiers in Pharmacology, 2019
A new, simple, sensitive, selective, rapid, and high-throughput liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed and validated for simultaneous quantification of Olmesartan and hydrochlorothiazide in human plasma ...
Arvind Kumar, Arvind Kumar, Surya Prakash Dwivedi, Tulika Prasad   +3 more
doaj   +2 more sources

Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.

New England Journal of Medicine, 2023
BACKGROUND Nephrolithiasis is one of the most common conditions affecting the kidney and is characterized by a high risk of recurrence. Thiazide diuretic agents are widely used for prevention of the recurrence of kidney stones, but data regarding the ...
N. Dhayat, O. Bonny, B. Roth, Andreas Christe, Alexander Ritter, N. Mohebbi, Nicolas Faller, Lisa Pellegrini, G. Bedino, R. Venzin, P. Grosse, Carina Hüsler, I. Koneth, C. Bucher, R. Del Giorno, L. Gabutti, M. Mayr, Urs Odermatt, F. Buchkremer, T. Ernandez, C. Stoermann-Chopard, D. Teta, B. Vogt, M. Roumet, Luca Tamò, G. Cereghetti, S. Trelle, D. Fuster   +27 more
semanticscholar   +1 more source

Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events.

New England Journal of Medicine, 2022
BACKGROUND Whether chlorthalidone is superior to hydrochlorothiazide for preventing major adverse cardiovascular events in patients with hypertension is unclear.
A. Ishani, W. Cushman, S. Leatherman, R. Lew, P. Woods, P. Glassman, A. Taylor, Cynthia Hau, Alison Klint, Grant D Huang, M. Brophy, L. Fiore, Ryan E Ferguson   +12 more
semanticscholar   +1 more source

Thiazide and the Thiazide-Like Diuretics: Review of Hydrochlorothiazide, Chlorthalidone, and Indapamide.

American Journal of Hypertension, 2022
The term thiazide is universally understood to refer to diuretics which exert their principal action in the distal tubule. The thiazide class is heterogenous, and can be further subdivided into compounds containing the benzothiadiazine ring structure ...
M. Ernst, Michelle A. Fravel
semanticscholar   +1 more source